Clinical trials
Neoplasm Metastasis trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
152 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 10 |
| 2013 | 10 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 8 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 17 |
| 2022 | 13 |
| 2023 | 6 |
| 2024 | 12 |
| 2025 | 9 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 66 |
| Active, not recruiting | 32 |
| Recruiting | 29 |
| Terminated | 21 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 24 |
| Eli Lilly and Company | 22 |
| Pfizer | 13 |
| Novartis Pharmaceuticals | 11 |
| Daiichi Sankyo | 9 |
| AbbVie | 5 |
| Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 4 |
| Astellas Pharma Inc | 3 |
| EMD Serono Research & Development Institute, Inc. | 3 |
| Amgen | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 152 |
| Neoplasms | 38 |
| Carcinoma, Non-Small-Cell Lung | 34 |
| Breast Neoplasms | 29 |
| Colorectal Neoplasms | 18 |
| Stomach Neoplasms | 11 |
| Lung Neoplasms | 10 |
| Endometrial Neoplasms | 9 |
| Prostatic Neoplasms | 9 |
| Carcinoma | 8 |
Trials
Showing 76 to 100 of 152. Each trial links to its page on Pharma Observatory.
52 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.